SCHEMBL3703447

SCHEMBL3703447

O=C(Oc1ccccn1)N(CCN1CCCC1)Cc1cc(-c2ccc3[nH]ccc3c2)cs1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 3/20 0.38
▸ ROCK2 O75116 3/20 0.37
▸ ROCK1 Q13464 3/20 0.37
▸ DRD3 P35462 4/20 0.37
▸ CTNNB1 P35222 1/20 0.35
▸ WNT3A P56704 1/20 0.35
▸ DRD2 P14416 3/20 0.34
▸ MAP3K11 Q16584 1/20 0.34
▸ HRH1 P35367 1/20 0.34
▸ HRH4 Q9H3N8 1/20 0.34
▸ PTGS2 P35354 1/20 0.34
▸ MAOA P21397 1/20 0.34
▸ DRD4 P21917 1/20 0.33
▸ CHEK1 O14757 1/20 0.33
▸ EPHX1 P07099 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ EPHX2 P34913 1/20 0.33
▸ SRPK1 Q96SB4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3703351 0.95 LTA4H (0.36) LTA4HROCK2ROCK1DRD3CTNNB1
SCHEMBL6731153 0.87 CTNNB1 (0.41) LTA4HROCK2ROCK1DRD3CTNNB1
SCHEMBL3696781 0.87 LTA4H (0.37) LTA4HROCK2ROCK1DRD3CTNNB1
SCHEMBL3702061 0.83 ROCK2 (0.43) LTA4HROCK2ROCK1DRD3DRD2
SCHEMBL6730552 0.83 OPRK1 (0.41) LTA4HROCK2ROCK1DRD3CTNNB1
SCHEMBL3695896 0.82 DRD3 (0.37) LTA4HROCK2ROCK1DRD3CTNNB1
SCHEMBL3695681 0.80 ROCK2 (0.40) LTA4HROCK2ROCK1DRD3DRD2
SCHEMBL3699846 0.78 ROCK2 (0.38) LTA4HROCK2ROCK1DRD3DRD2
SCHEMBL13604767 0.77 ROCK1 (0.38) LTA4HROCK2ROCK1
SCHEMBL3702481 0.76 CYP17A1 (0.37) LTA4HROCK2ROCK1MAP3K11CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1851199-B1 SUBSTITUTED BIS ARYL AND HETEROARYL COMPOUNDS AS SELECTIVE 5HT2A ANTAGONISTS AVENTIS PHARMA INC (US) 2012-05-16 — — EP claimed
Send feedback